SCHEMBL1923760

SCHEMBL1923760

NC(=O)c1[nH]cc(C(=O)O)c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 1/20 0.56
HTT P42858 1/20 0.56
RAB9A P51151 1/20 0.56
KDR P35968 8/20 0.55
PDGFRB P09619 3/20 0.55
GRIK1 P39086 7/20 0.54
KIT P10721 3/20 0.50
FLT3 P36888 3/20 0.50
NTRK1 P04629 2/20 0.50
NTRK2 Q16620 2/20 0.50
AURKB Q96GD4 2/20 0.50
JAK2 O60674 1/20 0.50
RET P07949 1/20 0.50
CDK8 P49336 1/20 0.50
NTRK3 Q16288 1/20 0.50
PLK4 O00444 1/20 0.50
AURKA O14965 1/20 0.50
ROCK2 O75116 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1924738 0.89 EPHX2 (0.51) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL1924916 0.87 RIPK1 (0.47) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL1924440 0.86 ROCK2 (0.49) MEN1KMT2AMAPTRAB9AKDR
SCHEMBL1924799 0.86 BRAF (0.49) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL1924035 0.85 CA12 (0.53) KDRPDGFRBGRIK1KITFLT3
SCHEMBL1925498 0.84 RIPK1 (0.49) MEN1KMT2AMAPTKDRPDGFRB
SCHEMBL1924589 0.84 CSF1R (0.58) MEN1KMT2AKDRPDGFRBKIT
SCHEMBL1923695 0.84 CDK8 (0.47) KDRKITFLT3NTRK1AURKB
SCHEMBL1923967 0.84 MEN1 (0.51) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL1926566 0.83 KDR (0.56) KDRPDGFRBCDK8FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP claimed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO claimed
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP disclosed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP disclosed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO disclosed